TimesSquare Capital Management LLC Makes New $15.18 Million Investment in CeriBell, Inc. $CBLL

TimesSquare Capital Management LLC bought a new stake in shares of CeriBell, Inc. (NASDAQ:CBLL) in the second quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund bought 780,552 shares of the company’s stock, valued at approximately $15,182,000. TimesSquare Capital Management LLC owned approximately 2.06% of CeriBell as of its most recent SEC filing.

Several other hedge funds have also made changes to their positions in CBLL. Strs Ohio purchased a new position in shares of CeriBell during the first quarter valued at $27,000. Caitong International Asset Management Co. Ltd lifted its stake in CeriBell by 3,971.0% in the fourth quarter. Caitong International Asset Management Co. Ltd now owns 1,262 shares of the company’s stock worth $28,000 after acquiring an additional 1,231 shares during the period. Zurcher Kantonalbank Zurich Cantonalbank purchased a new stake in CeriBell in the third quarter worth about $33,000. CWM LLC grew its holdings in CeriBell by 1,178.5% during the 4th quarter. CWM LLC now owns 1,841 shares of the company’s stock worth $40,000 after acquiring an additional 1,697 shares in the last quarter. Finally, Tower Research Capital LLC TRC increased its position in CeriBell by 353.8% during the 2nd quarter. Tower Research Capital LLC TRC now owns 2,310 shares of the company’s stock valued at $43,000 after purchasing an additional 1,801 shares during the period.

Insiders Place Their Bets

In other news, CTO Raymond Woo sold 1,966 shares of the firm’s stock in a transaction on Thursday, May 21st. The stock was sold at an average price of $18.00, for a total value of $35,388.00. Following the completion of the sale, the chief technology officer owned 195,682 shares of the company’s stock, valued at $3,522,276. This trade represents a 0.99% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Also, Director Joseph Michael Taylor sold 13,095 shares of the business’s stock in a transaction on Thursday, August 13th. The stock was sold at an average price of $23.40, for a total value of $306,423.00. Following the transaction, the director owned 48,478 shares in the company, valued at approximately $1,134,385.20. This trade represents a 21.27% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. In the last ninety days, insiders sold 313,780 shares of company stock valued at $6,241,749. 17.70% of the stock is currently owned by company insiders.

Analyst Ratings Changes

Several equities research analysts have recently weighed in on CBLL shares. Canaccord Genuity Group upped their price target on shares of CeriBell from $25.00 to $26.00 and gave the stock a “buy” rating in a research report on Tuesday, August 11th. BTIG Research reissued a “buy” rating and issued a $28.00 price objective on shares of CeriBell in a research note on Tuesday, August 11th. Finally, Weiss Ratings upgraded CeriBell from a “sell (e+)” rating to a “sell (d-)” rating in a report on Thursday. One investment analyst has rated the stock with a Strong Buy rating, four have issued a Buy rating and one has given a Sell rating to the company. According to MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and a consensus price target of $22.00.

CeriBell Stock Performance

Shares of CeriBell stock opened at $24.40 on Tuesday. The company has a market capitalization of $936.47 million, a PE ratio of -13.86 and a beta of 0.81. The company has a 50-day simple moving average of $19.06 and a two-hundred day simple moving average of $19.10. CeriBell, Inc. has a one year low of $10.85 and a one year high of $24.44. The company has a debt-to-equity ratio of 0.16, a quick ratio of 8.79 and a current ratio of 9.18.

CeriBell (NASDAQ:CBLL) last released its quarterly earnings results on Monday, August 10th. The company reported ($0.51) earnings per share for the quarter, missing analysts’ consensus estimates of ($0.47) by ($0.04). CeriBell had a negative net margin of 64.73% and a negative return on equity of 44.85%. The firm had revenue of $28.10 million during the quarter, compared to the consensus estimate of $27.28 million. Research analysts expect that CeriBell, Inc. will post -1.96 EPS for the current fiscal year.

CeriBell Profile

CeriBell Corp (NASDAQ: CBLL) is a healthcare technology company specializing in the design, manufacture and sale of automated newborn hearing screening devices. The company offers a suite of medical diagnostic tools based on otoacoustic emissions (OAE) and auditory brainstem response (ABR) technologies, enabling early detection of auditory impairments in infants. CeriBell’s solutions are used in hospitals, birthing centers and audiology clinics to support universal newborn hearing screening programs aimed at improving language development outcomes through prompt intervention.

The company’s product portfolio includes handheld and desktop screening units, proprietary software for data management, and accessories designed to streamline testing workflows.